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a b s t r a c t
Apoptosis may be regulated by oxidants such as peroxynitrite (ONOO). The tumour
suppressor, p53, has been reported to play a crucial role in apoptosis induced by oxidants,
therefore we assessed the ability of a ONOO donor, GEA 3162, to activate caspases and
induce mitochondrial permeability in a p53-deficient murine bone marrow cell line, Jaws II.
Furthermore, these cells were stably transfected with Bcl-2, in order to investigate the
impact of this survival protein on ONOO-induced apoptosis. GEA 3162 activated caspases
and induced loss of mitochondrial membrane potential in Jaws II cells. In particular,
caspases 3 and 2 were activated, alongside minor activation of caspases 8 and 9, and
apoptosis was partially dependent upon p38 MAP kinase activation, with little or no role
for JNK. Overexpression of Bcl-2 abolished activation of all caspases and reduced the change
inmitochondrial membrane potential. Thus, we have demonstrated that the ONOO donor,
GEA 3162, induces apoptosis in Jaws II murine myeloid cells despite lacking functional p53,
via a pathway that principally involves caspases 2 and 3 andmitochondrial changes. This is
blocked by overexpression of Bcl-2 via a mechanism that does not appear to merely reflect
stabilisation of the mitochondrial membrane.
# 2007 Elsevier Inc. All rights reserved.
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Abbreviations: GEA 3162, 1,2,3,4-oxatriazolium,5-amino-3-(3,4-dichlorophenyl)-chloride; STSP, staurosporine; GFP, green fluorescent
protein; Jaws II-GFP, p53-deficient murine bone marrow cells stably transfected with a vector encoding GFP; Jaws II-Bcl-2, p53-deficient
murine bonemarrow cells stably transfectedwith a vector encoding GFP and the survival protein Bcl-2; JNK, c-Jun N-terminal kinase; MAP
kinase, mitogen activated protein kinase; NO, nitric oxide; ONOO, peroxynitrite
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Apoptosis is a physiological form of programmed cell death
that plays important roles in embryogenesis, inflammation
and the safe and efficient clearance of damaged or unwanted
cells. This process is characterised by cellular and nuclear
condensation, maintenance of cell membrane integrity, the
exposure of recognitionmolecules for phagocytic removal and
internucleosomal DNA fragmentation [1]. During apoptotic
cell death, a range of cysteine proteases called caspases are
necessarily activated,which cleave proteins after aspartic acid
residues following activation from their zymogen forms [2].
There are two principal pathways for the execution of
apoptosis; a death receptor pathway and a stress pathway, as
reviewed by Wyllie [1], and Zimmermann et al. [3]. The
extrinsic death receptor-mediated pathway involves engage-
ment of ligands such as tumour necrosis factor-a (TNF-a) or
Fas ligand (FasL) with the appropriate receptor and proceeds
through activation of caspase 8 (initiator caspase) and caspase
3, which is critical in cleaving cellular components to drive the
irreversible dismantling of the cell. Additionally, the mito-
chondrial pathway described below can be activated through
death receptor ligation via translocation of the truncated
(active) form of Bid (tBid) to the mitochondria following
cleavage by caspase 8, as an amplification mechanism.
The intrinsic pathway occurs in response to cellular
damage or external stresses, and mitochondria play a central
role in this pathway. Activation of the stress pathway leads to
mitochondrial changes, in which the membrane potential is
lost, causing mitochondrial permeability. This allows the loss
of pro-apoptotic factors from the mitochondria, formation of
an ‘apoptosome’, and activation of caspase 9 (initiator
caspase) and ultimately caspase 3. These mitochondrial
changes are tightly regulated by the balance of pro- and
anti-apoptotic members of the Bcl-2 proto-oncogene family
[4], which interact with each other and the mitochondrial
membrane to either promote or prevent mitochondrial
permeabilisation. Pro-apoptotic members of the Bcl-2 family
include Bax, Bad, Bid and Bak and tend to be locatedwithin the
cytosol, whereas anti-apoptotic members such as Bcl-2, Bcl-XL
and A1 are predominantly found on the mitochondrial
membrane itself.
Mitochondrial changes in response to cellular damage or
stress are often preceded by activation of the transcription
factor, p53. This tumour suppressor induces apoptotic cell
death if DNA damage is severe or irreparable. It controls
transcription levels of several proteins involved in apoptosis in
order to push the balance towards cell death, notably by
increasing the pro-apoptotic proteins Fas (CD95), Bax, Bid,
Noxa and Puma [4,5] and down-regulating expression of the
anti-apoptotic protein, Bcl-2 [6].
Furthermolecules with a role in the regulation of apoptosis
are the mitogen activated protein (MAP) kinases. The JNK and
p38 MAP kinase families are involved in the cellular response
to stress and are important in apoptosis [7]. However, the
relationship between pro- and anti-apoptotic effects of these
kinases is complex, and may be cell type or stimulus-specific
[8].
Peroxynitrite (ONOO) is a powerful oxidant species
formed through the combination of NO and superoxide anion(O2
). Inflammatory cells are able to produce both species
when activated [9], and ONOO is thought to have bactericidal
effects in acute inflammation, and has additionally been
shown to promote apoptosis in several cell types [10,11].
Previous studies have demonstrated that the ONOO
donor, GEA 3162, is able to promote apoptotic cell death in
neutrophils [12–14] in a caspase-dependentmanner. However,
the effects of this compound on apoptosis have not been
investigated in other cells of themyeloid lineage.We set out to
investigate the effects of the ONOO donor, GEA 3162, on
apoptosis in the Jaws II murine immature bone marrow cell
line, which is derived from the p53/ mouse. We hypothe-
sised that GEA 3162 would initiate apoptosis in these cells
despite their lack of p53, and that overexpression of the
survival protein, Bcl-2, would abolish this response through
stabilisation of the mitochondrial membrane.
2. Materials and methods
2.1. Cell culture
Immaturemouse bonemarrow cells (Jaws II; ATCC,Manassas,
VA) [15] were cultured in alpha minimum essential medium
with ribonucleosides, deoxyribonucleosides enriched with
20% heat-inactivated fetal bovine serum (Hyclone Labora-
tories, Logan, UT), L-glutamine 4 mM, and sodium pyruvate
1 mM (all purchased from BioWhittaker, Inc., Walkersville,
MD) in the presence of 5 ng/ml GM-CSF (R&D Systems, Inc.,
Minneapolis, MN). Cells were seeded into T75 culture flasks.
Flasks were incubated at 37 8C in a humidified atmosphere
containing 5% CO2 until approximately 70–80% confluence
was achieved. Cells were passaged 1 in 4 every 3–4 days.
In order to harvest the cells, suspension cellswere removed
into 50 ml centrifuge tubes before addition of trypsin-EDTA to
the flasks. Cells were incubated until the adherent cells
detached and were removed into the appropriate centrifuge
tube, and cell numbers counted using a haemacytometer. The
tubes were centrifuged (1000 rpm, 10 min) to form a cell pellet,
then supernatant was aspirated and the cells resuspended in
Jaws II medium at a density of 5  105 cells/ml before being
plated out as required.
2.2. Construction and stable expression of Bcl-2 cDNA
cDNA encoding the intronless open reading frame of the 717
base pair human Bcl-2a (pORF-hBcl-2) (InvivoGen, San Diego,
CA) was cloned into shuttle plasmid SL1180 (Amersham
Pharmacia Biotech, Piscataway, NJ) utilizing the Nco I and Nhe
I (New England BioLabs, Inc., Beverly, MA) restriction enzyme
sites. The pORF-hBcl-2 was subsequently cloned into the EcoR
I and Xho I (New England BioLabs, Inc., Beverly, MA) sites on
the multiple cloning region of the bicistronic retroviral
expression plasmid, pBMN-IRES-enhanced green fluorescent
protein (EGFP) (kindly provided by Dr. Gary Nolan, Stanford
University, Palo Alto, CA) [16]. High titer second-generation
helper free retrovirus was produced by calcium phosphate
mediated transfection of the Phoenix ecotropic packaging cell
line (ATCC, Manassas, VA) with either 24 mg of the hBcl-2
expression plasmid or pBMN-IRES-EGFP control plasmid.
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transfection and filtered through a Millex-HV 0.45 mm filter
(Millipore Corp., Bedford, MA). For transduction, cell culture
media from 70% confluent JAWS II cells in 6-well plates
(Corning Inc., Corning, NY) were replaced with 2.5 ml of
retrovirus supernatant and centrifuged for 2 h (1430  g at
32 8C) and then incubated for 10 h (5% CO2, 37 8C). Upon
completion of the incubation period, retroviral supernatant
was replaced by appropriate normal growth medium for each
cell type. Cells were sorted for stable retrovirus transfection
based on EGFP expression using a FACVantage SE cell sorter
(BecktonDickinsonCorp., Franklin Lakes, NJ). High-expressing
cells were collected and used in subsequent experiments, as
previously published [17].
2.3. Bcl-2 western blot
JAWS II-Bcl-2 or JAWS II-GFP cells were lysed in 60 mm tissue
culture dishes (BectonDickinson, Franklin Lakes, NJ) using ice-
cold modified radioimmunoprecipitation (RIPA) buffer (Tris–
HCl 50 mM, NP-40 1%, Na-deoxycholate 0.25%, NaCl 150 nM,
Na3VO4 1 mM, NaF 50 mM) (all purchased from Sigma, St.
Louis, MO) with one Complete MiniTM tablet (Roche, Indiana-
polis, IN) per 10 ml of modified RIPA buffer. Cell debris was
removed by centrifugation at 14,000  g for 15 min at 4 8C.
Supernatant was collected and stored at 20 8C. BCA Protein
Assay kit (Pierce, Rockford, IL) was used to measure protein
concentrations of cell lysates. Cell lysates, 20 mg total protein
per lane, were resolved on Novex1 4–20% Tris–glycine gels
(Invitrogen, Carlsbad, CA) and transferred onto methanol
activated ImmobilonTM PVDF membrane (Millipore Co., Bed-
ford, MA). Membrane was blocked with 5% milk (Western
Family Foods, Portland, OR) in TBS (Sigma, St. Louis, MO) at
4 8C overnight. After blocking, membrane was probed with
mouse anti-human Bcl-2 monoclonal antibody (#610539 BD
Transduction Labs, San Diego, CA) at a 1:1000 dilution in TBS
with 1% tween-20 (TBST) (Sigma, St. Louis, MO) for 1 h at room
temperature. Membrane was washed three times in TBST.
Goat anti-mouse IgG HRP conjugated secondary antibody
(#610094 BD Transduction Labs, San Diego, CA) was applied at
1:10,000 dilution in TBST and incubated for 1 h at room
temperature. Membrane was washed four times in TBST
followedby twowashes in TBS. Enhanced chemiluminescence
(ECL) plus (Amersham, Buckinhamshire, England) was applied
for 5 min and chemiluminescence was detected on radio-
graphic film (Eastman Kodak Co., Rochester, NY).
2.4. MTT assay
A colorimetric assay using (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide (MTT) provides ameasure of the
cytotoxicity of agents. The mitochondria of viable cells
metabolise MTT to turn the solution from yellow to purple,
which can be measured using a spectrophotometer at a
wavelength of 500–600 nm.
In order tomeasure cell viability following exposure to GEA
3162 (30–100 mM), 20,000 cells perwell (40 ml) were plated into a
96-well plate, which was then incubated at 37 8C overnight,
before addition of 50 ml medium. GEA 3162 (10 ml of 10 stock)
was added to final concentrations as shown in the figurelegends (concentrations that have previously been shown to
promote apoptosis in human neutrophils [18]) and the plate
incubated for 4 h. The MTT assay was then carried out
according to the manufacturers’ instructions. Briefly, 10 ml of
MTT solution was added to each well and the plate incubated
at 37 8C for 4 h before addition of 100 ml of solubilisation
solution. The plate was then read with a test wavelength of
570 nm and a reference wavelength of 630 nm.
2.5. Homogeneous caspase activation
Caspase proteases are activated during apoptotic cell death.
Fluorogenic substrates can be cleaved by caspases, giving a
quantitative indication of caspase enzyme activity which can
be measured by fluorescent plate reader.
In order to measure levels of caspase activation in Jaws II
cells treated with GEA 3162 (Alexis Biochemicals, San Diego,
CA) or the pan-kinase inhibitor, staurosporine (STSP; Sigma,
St. Louis, MO), 20,000 cells per well (40 ml) were plated into an
opaque 96-well plate, which was then incubated at 37 8C
overnight. GEA 3162 or STSP (10 ml of 10 stock) were added to
final concentrations as shown in the figure legends (concen-
trations that have previously been shown to promote
apoptosis in human neutrophils [18]) in the absence or
presence of the pan-caspase inhibitor, zVAD (100 mM). The
volume in each well was made up to 100 ml with 50 ml culture
medium. Following 4 h incubation at 37 8C (time point
determined by preliminary time course studies; data not
shown), caspase activation was measured using a homo-
geneous caspase detection kit (Roche, Indianapolis, IN)
according to the manufacturer’s instructions. Briefly, 100 ml
of caspase substrate was added to each well, plus two wells
containing positive control lysates provided in the kit, and two
wells containingmedium alone as ‘blank’ wells. The plate was
then incubated at 37 8C for at least 1 h before fluorescencewas
read using a fluorescent plate readerwith excitation at 485 nm
and emission measured at 530 nm. Background fluorescence
from ‘blank’ wells was then subtracted from all values
obtained.
The same protocol was followed for other experiments
using the pharmacological inhibitors, SP600125 (JNK inhibitor)
and SB203580 (p38 inhibitor). For these experiments, the
inhibitor was diluted in Jaws II culture medium at 2 desired
concentration before addition of 50 ml to the wells at a final
concentration of 10–50 mM.
2.6. Specific caspase activation
Individual caspases 2, 3, 8 and 9were also assessed for activity
using a fluorescent plate assay, in order to investigate possible
pathways through which GEA 3162-induced apoptosis may
proceed.
Jaws II-GFP and Jaws II–Bcl-2 cells were harvested as
described above. 2 million cells were seeded into T25 flasks in
4.5 ml culture medium and incubated overnight at 37 8C. The
following day, 500 ml of medium (controls) or GEA 3162 (final
concentration 30–100 mM) were added, and flasks were
incubated for 4 h at 37 8C. Cells were then harvested and
centrifuged (1000 rpm, 5 min). Activity of caspases 2, 3, 8 and 9
was then assessed using the ApoAlert Caspase Profiling kit
b i o c h em i c a l p h a rma co l o g y 7 4 ( 2 0 0 7 ) 1 0 3 9 – 1 0 4 91042(Clontech, Mountain View, CA) according to the manufac-
turers’ instructions. Briefly, cell pellets were resuspended in
400 ml of ice-cold cell lysis buffer and incubated on ice for
10 min. Following lysis, tubes were vortexed and 50 ml of cell
lysate added in duplicate to wells containing immobilised
substrate for individual caspases plus 50 ml of 2 reaction
buffer. The plate was then covered and incubated at 37 8C for
2 h. Cleavage of caspase substrates was then measured by
fluorescent plate reader, with excitation at 360 nm and
emission measured at 460 nm.
2.7. Mitochondrial membrane permeability assay
A potential difference exists across the mitochondrial mem-
brane in viable cells. However, during apoptosis that proceeds
through the stress or mitochondrial pathway, the potential
difference is lost and the mitochondria become permeable.
This loss of potential difference can bemeasured by the use of
a fluorescent dye that accumulates in the mitochondria of
viable cells and fluoresces red, but is unable to enter the
mitochondria of apoptotic cells and fluoresces green in the
cytosol. The ratio of red:green fluorescence gives an indication
of the proportion of viable:apoptotic cells, and can be
measured using a fluorescent plate reader.
The change in mitochondrial membrane potential during
apoptosis in Jaws II cells treated with GEA 3162 or STSP was
measured using the Mit-E-c apoptosis detection kit (Biomol
International, Plymouth Meeting, PA) according to the man-
ufacturer’s instructions. Cells were harvested as described
above and 10,00,000 cells added per well of a 6-well plate in a
total volumeof 2 ml. Following overnight incubation at 37 8C to
allow cells to adhere, culture medium (control), STSP or GEA
3162 were added to the wells to final concentrations shown inFig. 1 – FACS analysis for transfection of JAWSII cells with retro
transfected to overexpress Bcl-2 were selected based on linked
demonstrated minimal fluorescence. (B) Cells transfected with B
GFP positive cells were sorted based on gate M2. Post-sort anal
these cells were sorted again for the highest GFP expressors (D
passages: wild type (black line), transfected cells (grey line), higthe figure legends, then cells were incubated for a further 4 h.
The cells were then harvested and tubes were centrifuged
(1000 rpm, 5 min) to pellet the cells. Supernatant was then
aspirated and cells were resuspended in 1 ml Mit-E-c solution
and incubated at 37 8C for 15 min. Assay buffer (2 ml) was then
added and the tubes centrifuged (1000 rpm, 5 min) before
resuspension of the cell pellet in 1 ml assay buffer and further
centrifugation (1000 rpm, 5 min) to wash the cells. Cells were
resuspended once more in 1 ml assay buffer before duplicate
aliquots of 100 ml were transferred from each tube to an
opaque 96-well plate, which was then analysed by fluorescent
plate readerwith excitation at 485 nmand emissionmeasured
at 590 nm (red fluorescence) and 530 nm (green fluorescence).
The ratio of red to green fluorescence was then calculated.
2.8. Statistical analysis
Each experimentwas carried out using duplicate samples for a
minimum of three replicates, and the mean and standard
error of the combined data was calculated. Significance
between results was analysed using repeated measures
ANOVA. Student–Newman–Keuls post-test was used to
determine significance differences between treatments. A p-
value < 0.05 was considered statistically significant.
3. Results
3.1. Characterisation of the Bcl-2 overexpressing Jaws II
cell line
Jaws II cells transfectedwith a vector encoding GFP/Bcl-2 were
sorted for high-expressing cells on the basis of their greenvirus containing bcl-2-IRES-GFP. Cells successfully
GFP expression in FL1. In panel (A) wild type cells
cl-2-IRES-GFP retrovirus showed bimodal fluorescence and
ysis (C) showed a wide range in fluorescent intensity and
). Panel (E) shows the population of cells after several
h-expressing cells (black area).
Fig. 3 – Effect of GEA 3162 on Jaws II cell viability. GFP or Bcl-
2-overexpressing Jaws II cells were exposed to GEA 3162
(30–100 mM) for 4 h before assessment of cell viability by
MTT assay. Data represents meanW S.D. following n = 2
experiments. Asterisks represent significant (p < 0.05)
difference from control (untreated) cells for each cell type
(repeated measures ANOVA with Student–Newman–Keuls
post-test).
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escence (Fig. 1A), which was shifted to a bimodal fluorescence
profile following retroviral transfection (Fig. 1B). The higher
expressing cells, corresponding to gate M2, were collected.
Analysis of these cells showed a wide spread of fluorescence
(Fig. 1C), so they were once again sorted for the highest
expressing cells (Fig. 1D)whichwere collected and cultured for
use in these studies.
Western blot analysis was carried out to demonstrate the
effectiveness of the transfection of Bcl-2 into the Jaws II cell
line. These blots clearly show that Jaws II-Bcl-2 cells express
large quantities of Bcl-2 protein, that are not detectable in cells
containing GFP vector alone (Fig. 2A, lanes 1 and 2). The blot
was stripped and reprobed for actin to demonstrate that lane
loading was equal for both Jaws II-GFP and Jaws II-Bcl-2 cells.
Expression was stable and did not diminish over time (Fig. 2B),
as cell lysates generated at both passage 4 (lanes 1 and 2) and
at passage 12 show marked Bcl-2 expression in Jaws II-Bcl-2
cells but not in Jaws II-GFP cells (lanes 3 and 4).
3.2. Effects of GEA 3162 on cell viability in Jaws II-GFP and
Jaws II-Bcl-2 cells
Assessment of Jaws II cell viability by MTT assay following
exposure to GEA 3162 (30 or 100 mM) for 4 h showed a decrease
in viability in Jaws II-GFP cells (Fig. 3), with a significant
(p < 0.05) effect seen with the higher concentration. Jaws II-
Bcl-2 cells also showed a slight decrease in viability, althoughFig. 2 – Transfection of Jaws II cells with human Bcl-2. (A)
Western blot of cell lysates prepared from Jaws II cells
transfected to overexpress Bcl-2 (Jaws II-Bcl-2) or vector
alone (Jaws II-GFP), showing expression of Bcl-2 in Jaws II-
Bcl-2 but not Jaws II-GFP cells, and equal lane loading
using actin. (B) Bcl-2 overexpression was stable over
multiple passages. Western blot of different passages of
JAWS II cells stably transfected to overexpress human Bcl-
2 or GFP. Human Bcl-2 protein levels were unchanged from
passage 4 to passage 12.this effect was reduced compared to the control cells and was
associated with more variability in absorbance measured.
Both sets of cells continued to exclude Trypan Blue following
treatment with GEA 3162 (data not shown).
3.3. Total caspase activation in response to GEA 3162 in
Jaws II-GFP and Jaws II-Bcl-2 cells
Measurement of caspase activation in Jaws II cells showed
enhanced activation in cells containing the GFP vector in
response to GEA 3162. Following 4 h incubation in medium
alone, Jaws II-GFP cells and the Bcl-2-overexpressing cells
showed no significant difference in the basal level of
fluorescence. In the presence of STSP (200 nM), however,
fluorescence was increased ( p > 0.05 compared with GFP
control) in Jaws II-GFP cells (Fig. 4A). Overexpression of Bcl-2
reduced the increase in fluorescence in response to STSP
( p > 0.05), although fluorescence did not return to control
levels. In the presence of the pan-caspase inhibitor, zVAD
(100 mM), fluorescence levels were similar in GFP cells, GFP
cells plus STSP ( p > 0.05), Bcl-2 overexpressing cells
( p > 0.05) and Bcl-2 cells plus STSP ( p > 0.05). Although
the presence of zVAD was insufficient to return fluorescence
back to control levels, it did markedly reduce the level of
caspase activation in response to STSP in both Jaws II-GFP
and Jaws II-Bcl-2 cells, although this was not significantly
different from STSP-treated cells in the absence of zVAD
( p > 0.05).
When Jaws II cells were exposed to the ONOO donor,
GEA 3162 (30–100 mM), for 4 h, caspase activation increased
in a concentration-dependent manner in Jaws II-GFP
cells (Fig. 4B), with those treated with 100 mM GEA 3162
producing a statistically significant ( p < 0.05) degree of
activation. In contrast, in the presence of 100 mM zVAD,
Fig. 4 – GEA 3162 induces caspase activation in Jaws II-GFP
but not Jaws II-Bcl-2 cells. GFP or Bcl-2-overexpressing
Jaws II cells were exposed to (A) STSP (200 nM) or (B) GEA
3162 (30–100 mM) for 4 h before assessment of
homogeneous caspase substrate cleavage (white bars). As
an internal control for the assay, cells were also incubated
with the pan-caspase inhibitor, zVAD (100 mM; black bars).
Data represents meanW S.E.M. following n = 4
experiments performed in duplicate. Asterisks represent
significant (p < 0.05) difference from control (untreated)
cells for each cell type, and hashes represent significant
differences in fluorescence in the absence and presence of
zVAD for a given treatment (repeated measures ANOVA
with Student–Newman–Keuls post-test).
Fig. 5 – GEA 3162 induces loss of mitochondrial membrane
potential that is reduced by Bcl-2 overexpression. GFP or
Bcl-2-overexpressing Jaws II cells were exposed to (A)
STSP (200 nM) or (B) GEA 3162 (30–100 mM) for 4 h before
assessment of mitochondrial permeability. Cells were
harvested and centrifuged and cell pellets resuspended
and incubated in a solution of fluorescent dye before
washing, then red and green fluorescence was measured.
The ratio of red (intact mitochondrial membrane potential)
to green (mitochondrial membrane potential lost) cells is
indicative of the extent of mitochondrial-dependent
apoptosis. Data represents meanW S.E.M. following n = 4
experiments performed in duplicate. Asterisks represent
significant (p < 0.05) difference from control (untreated)
cells for each cell type (repeated measures ANOVA with
Student–Newman–Keuls post-test).
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significant difference was seen between treated and
untreated cells ( p > 0.05).
Overexpression of Bcl-2 reduced the caspase activation
seen in Jaws II cells on exposure to GEA 3162. Treatment of
these cells with GEA 3162 produced no significant difference in
fluorescence from control (untreated) cells (p > 0.05). There
was, however, a significant decrease in caspase activation
levels in Bcl-2-overexpressing cells exposed to 100 mM GEA
3162, compared to cells containing the GFP vector alone under
the same conditions (p < 0.05). Addition of zVAD (100 mM) had
little effect in Jaws II-Bcl-2 cells, but reduced fluorescence
levels very slightly (p > 0.05), demonstrating that the vast
majority of caspase activity was already inhibited by the
overexpression of Bcl-2.3.4. Involvement of mitochondrial permeabilisation in
apoptosis
The loss of mitochondrial membrane potential (cM) that is
characteristic of the stress pathway of apoptosis was
measured through the use of a fluorescent dye. Viable cells
fluoresce red and apoptotic cells fluoresce green, therefore the
red:green fluorescence ratio decreases with increasing levels
of apoptotic cell death. STSP (200 nM, 4 h) promoted the loss of
cM in Jaws II cells containing the GFP vector alone, while
overexpression of Bcl-2 caused a reduction in the change of
mitochondrial potential (Fig. 5A), thereby providing a protec-
tive effect against mitochondrial permeabilisation.
In Jaws II-GFP cells exposed to GEA 3162 (30–100 mM) for 4 h,
there was a concentration-dependent reduction in the
fluorescence ratio compared to control cells (Fig. 5B), with
exposure to 100 mM GEA 3162 producing a significant level of
mitochondrial permeability (p < 0.05). Again, the overexpres-
sion of Bcl-2 in Jaws II cells conferred some protection against
the loss of cM, although this was not complete. Cells exposed
Fig. 6 – Specific caspases activated by GEA 3162. GFP or Bcl-
2-overexpressing Jaws II cells were exposed to GEA 3162
(30–100 mM) for 4 h before assessment of the cleavage of
specific fluorogenic substrates for (A) caspase 3, (B)
caspase 8, (C) caspase 9 and (D) caspase 2. Cells were
harvested, centrifuged and lysed, then lysates incubated
with specific caspase substrates immobilised on a plate,
with fluorescence indicating the extent of caspase
activation. Data represents meanW S.E.M. following n = 4
experiments performed in duplicate. Asterisks represent
significant (p < 0.05) difference from control (untreated)
cells for each cell type, and hashes represent significant
differences between fluorescence in GFP and Bcl-2 cells for
a given treatment (repeated measures ANOVA with
Student–Newman–Keuls post-test).
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control (p > 0.05).
3.5. Activation of specific caspases
Analysis of specific caspase activation showed that exposure
of Jaws II-GFP cells to GEA 3162 leads to a large increase in the
activity of caspases 2 and 3, and a smaller increase in caspases
8 and 9 (Fig. 6). Treatment with 30 or 100 mM GEA 3162
produced a concentration-dependent increase in caspase 3
substrate cleavage in cells transfected with the GFP vector
alone, with fluorescence levels reaching approximately 230%
(p > 0.05) and 950% (p < 0.05) of control levels respectively.
Similarly, relatively high levels of activation were seen with
caspase 2, with 30 mM GEA 3162 producing around 160%
(p > 0.05) and 100 mM producing 650 % ( p < 0.05) of control
fluorescence. However, caspase 8 activation was less pro-
nounced, with fluorescence in response to 30 mM GEA 3162
being virtually identical to control (p > 0.05), and 100 mM
measured at 200% (p < 0.05) of control. Caspase 9 levels were
virtually identical in control and 30 mM GEA 3162-treated cells
(p > 0.05)while 100 mM-treated cells showed 185% (p > 0.05) of
control fluorescence. In contrast, overexpression of Bcl-2
greatly reduced or abolished all GEA 3162-induced increases in
fluorescence, and there was no significant difference between
any treatments in these cells for any of the caspases
measured, indicating that Bcl-2 overexpression prevents up-
regulation of the activity of multiple caspases in response to
ONOO.
3.6. Effects of MAP kinase inhibitors on total caspase
activity in Jaws II-GFP cells
Homogeneous caspase activity in the presence of JNK
(SP600125; 10–50 mM) and p38 (SB203580; 10–50 mM) MAP
kinase inhibitors was also measured in Jaws II-GFP cells
exposed to GEA 3162 (30–100 mM) for 4 h. SP600125 afforded
slight protection against GEA 3162-induced apoptosis at the
highest concentration (Fig. 7B). The level of fluorescence in
untreated (control) cells was unaffected by the presence of
10 mM (p > 0.05) or 50 mM (p > 0.05) of the JNK inhibitor. The
lower (30 mM) concentration of GEA 3162 caused a small
increase in caspase activity although this was not statistically
significant by repeated measures ANOVA ( p > 0.05). In the
presence of SP600125, fluorescence was not significantly
altered. Exposure to 100 mM GEA 3162 for 4 h caused a
significant increase in caspase activity (p < 0.05). Addition of
10 mM SP600125 caused a small increase in caspase activity
(p < 0.05 compared to untreated cells), but addition of 50 mM
SP600125 caused a small but statistically significant decrease.
While this was still significantly different from untreated
control cells, it was also a significant decrease compared to
cells exposed to GEA 3162 in the absence of the JNK inhibitor
(p < 0.05).
In contrast, SP600125 failed to affect caspase activation in
response to 200 nM STSP (Fig. 7A). STSP-treated cells exhibited
a significant increase in fluorescence compared to control
(p < 0.05) which was not abrogated by the presence of
SP600125, as fluorescence remained significantly different
from control.
Fig. 7 – Effect of JNK inhibition on GEA 3162-induced
apoptosis in Jaws II-GFP cells. Cells were exposed to (A)
STSP (200 nM) or (B) GEA 3162 (30–100 mM) in the absence
or presence of the JNK inhibitor, SP600125 (10–50 mM).
Total caspase activity was then measured by incubation
with fluorogenic caspase substrate for 1 h. Data represents
meanW S.E.M. following n = 5 experiments performed in
duplicate. Asterisks represent significant (p < 0.05)
difference from control (untreated) cells, and hashes
represent significant differences in fluorescence in the
absence and presence of SP600125 (repeated measures
ANOVA with Student–Newman–Keuls post-test).
Fig. 8 – Effect of p38 inhibition on GEA 3162-induced
apoptosis in Jaws II-GFP cells. Cells were exposed to (A)
STSP (200 nM) or (B) GEA 3162 (30–100 mM) in the absence
or presence of the p38 inhibitor, SB203580 (10–50 mM).
Total caspase activity was then measured by incubation
with fluorogenic caspase substrate for 1 h. Data represents
mean W S.E.M. following n = 3 experiments performed in
duplicate. Asterisks represent significant (p < 0.05)
difference from control (untreated) cells, and hashes
represent significant differences in fluorescence in the
absence and presence of SB203580 (repeated measures
ANOVA with Student–Newman–Keuls post-test).
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p38 inhibitor, SB203580 (10–50 mM) showed protection of Jaws
II-GFP cells from GEA 3162-induced apoptosis (Fig. 8B). The
inhibitor had no effect on apoptosis in untreated (control)
cells,with fluorescence at similar levels in the presence of 0, 10
and 50 mM SB203580 (p > 0.05 between conditions). Caspases
were activated in response to 30 mM GEA 3162 (p > 0.05
compared to untreated cells), and addition of 10 or 50 mM of
the p38 inhibitor had no effect on caspase activity (p > 0.05
versus no inhibitor). Increased caspase activity was also
detected on exposure to 100 mM GEA, However there was a
concentration-dependent reduction in fluorescence on addi-
tion of SB203580, with 50 mM producing a statistically
significant effect, bringing caspase activity down to a level
that is significantly different to 100 mM GEA 3162-treated cells
in the absence of inhibitor, and not significantly different from
untreated cells.
In contrast, inhibition of p38 enhanced STSP-induced
apoptosis in Jaw II-GFP cells (Fig. 8A), with specific inhibition
of p38MAP kinase providing an additive apoptotic effect to the
general kinase inhibition provided by STSP. Fluorescence
levels were elevated in response to 200 nM STSP. Addition of10 mM SB203580 in the presence of STSP increased fluores-
cence in a concentration-dependent manner, with 50 mM
having a significant effect ( p < 0.05 compared to STSP alone).
4. Discussion
Apoptotic cell death is regulated by NO and related species,
such as ONOO, in several cell types including myeloid-
derived leukocytes such as neutrophils, eosinophils and
monocytes/macrophages [10]. The biological effects of NO
and ONOO, including their effects on apoptosis, have
recently been comprehensively reviewed [19]. Some studies
have reported that p53 is required for apoptosis induced byNO
and/or ONOO in some cell types [20–22]. Other studies
suggest that p53 may be inactivated by ONOO [23] or that
apoptosis may proceed despite the absence of p53 [24].
Alternatively, lack of p53 may confer a degree of resistance
to NO/ONOO-stimulated apoptosis but other pathways may
contribute to cell death or compensate when p53 is lacking
[25–28]. In order to elucidate the dependence or otherwise of
apoptosis on p53, we investigated the effects of GEA 3162, a
b i o c h em i c a l p h a rma c o l o g y 7 4 ( 2 0 0 7 ) 1 0 3 9 – 1 0 4 9 1047ONOO donor similar to SIN-1 [14], on apoptosis in a murine
bone marrow cell line, Jaws II. This cell line is devoid of p53,
andwas studied containing either a vector encodingGFP alone
(control) or a vector coding for both GFP and the anti-apoptotic
protein, Bcl-2.
Although we have previously demonstrated that GEA 3162
simultaneously releases NO and O2
 in our system, and
produces the same profile of apoptotic events as SIN-1 [14],
other studies have found GEA 3162 to be a pure NO donor [29].
Furthermore, in culture conditions, factors such as CO2 may
cause significant decay of ONOO formed [30]. Thus, although
in this studywe refer to GEA 3162 as a ONOO donor, the exact
nature of the apoptogenic species is not known, and further
studies (e.g. using SOD or NO scavengers) would have to be
carried out to determinewhich species is responsible for these
effects.
Apoptosis is a process that is dependent on the action of
caspase proteases [1]. Therefore, total caspase activity was
measured in Jaws II cells to determine whether these
proteases are activated on exposure to GEA 3162, or STSP as
a control apoptosis-initiating stimulus. STSP increased cas-
pase activation in Jaws II-GFP cells, although this failed to
reach statistical significance. GEA 3162 also increased caspase
activity; the effect was clearly concentration-dependent and
there was a significant effect with the higher concentration.
When the pan-caspase inhibitor, zVAD, was added as an
internal control for the assay, fluorescence was reduced in all
conditions, demonstrating that fluorescence measured was
due to caspase activation. A significant difference was seen
between control cells exposed to 100 mM GEA 3162 in the
absence and presence of zVAD, therefore GEA 3162 specifically
enhances caspase activation. Thus, apoptosis proceeded
despite the absence of p53 in these cells, and correlates with
existing data that suggests that p53 is not essential for
apoptosis, but alternative and/or compensatory pathways are
involved.
Overexpression of Bcl-2 was protective against GEA 3162-
induced caspase activation, as no significant increase in
caspase activity was seen in Jaws II-Bcl-2 cells compared to
untreated cells of the same kind. However, a significant
difference was observed between treatment with 100 mM GEA
3162 in Jaws II-GFP compared with Jaws II-Bcl-2. Thus, it is the
overexpressed Bcl-2 that abrogates caspase activity. Similar
findings have previously been reported in macrophage cell
lines, which were protected from NO-induced apoptosis by
overexpression of Bcl-2 [31]. In that study, Bcl-2 was proposed
to neutralise the p53-dependent increase in Bax expression.
The absence of p53 in Jaws II cells implies that an alternative
mechanism of protection is also involved. One possibility is
the antioxidant activity of Bcl-2, which has been previously
described [32]. Alternatively, Bcl-2 may have a protective role
similar to that observed in C. elegans by its ortholog, CED-9.
CED-9 acts to sequester CED-4 (the worm equivalent of Apaf-
1), and prevent activation of CED-3 (caspase 3 in humans).
Therefore, it is possible that human Bcl-2 may have a similar,
more direct, role in caspase regulation, and there is some data
to support this proposal, as discussed by Cory and Adams [4].
Mitochondrial permeability was enhanced in Jaws II-GFP
cells on exposure to GEA 3162, suggesting that the mitochon-
drial pathway is involved in ONOO induced apoptosis inthese cells. Bcl-2 overexpression reduced the change in CM so
that it was no longer significantly different from control, but
this protection was incomplete. This is in agreement with
previous studies in ONOO treated thymocytes, in which Bcl-2
offered complete protection against caspase activation and
DNA fragmentation, but only partial inhibition of loss of CM
[33].
Measurement of specific caspases showed that GEA 3162
strongly activated caspases 2 and 3 in Jaws II-GFP cells, while a
lesser activity of caspases 8 and 9 was detectable. Such data
shows remarkable similarity to that obtained in HL-60 cells on
exposure to ONOO, in which activity of caspases 2 and 3 was
approximately 500% of control (untreated) levels, whereas
caspases 8 and 9 had a maximal activation of 200–210% of
control [34]. Interestingly, HL60 cells are also p53 null,
suggesting that this profile of caspase activity may occur in
response to ONOO in cells lacking this gene. The lack of
discernible phenotype in the caspase 2/ mouse points
towards a potential role for caspase 2 as a compensatory
molecule activated in the absence of other pro-apoptotic
proteins, such as p53. However, although it is possible that this
is a cell-specific apoptotic pathway seen in cells lacking
functional p53, a stimulus-specific effect in p53-replete cells in
response to ONOO cannot be ruled out. Further experiments
in other p53/ and p53+/+ cells, plus siRNA and repletion
studieswould need to be carried out to distinguish cell-specific
and stimulus-specific effects of ONOO.
Caspase 3 is the principal effector caspase involved in the
apoptotic cascade, and cleaves specific target proteins within
the cell, such as PARP, PKC-d, protein kinases and structural
proteins [35]. However, little is known about the role of
caspase 2 in apoptosis, as it has largely been ignored in
investigations of the apoptotic process, due to the lack of
phenotype in the knockout mouse. However, there have been
several suggestions regarding its function (particularly that it
acts just upstream of mitochondrial permeabilisation) and
these proposed functions are reviewed by Troy and Shelanski
[18]. A recent study also attributed caspase 2 function to an ER
stress pathway of apoptosis, functioning as both an initiator
and effector caspase [36]. As ER stress has been implicated in
the apoptotic response to NO/ONOO in p53-deficient murine
microglial cells [24], this is a feasible suggestion for the
mechanism by which ONOO induces apoptosis in Jaws II
cells.
Caspase 9 activation measured by the profiling assay
confirmed the involvement of mitochondria in apoptosis
elicited by GEA 3162 in Jaws II-GFP cells. Cleavage of the
caspase 8 substrate at low levels suggests either non-specific
cleavage by high levels of caspases 2 and 3, or a potential role
for death receptor clustering that is amplified via the caspase
cascade. It has been proposed that reactive oxygen species
may induce ligand-independent death receptor clustering in
lipid rafts and subsequent caspase activation [37]. It remains
to be seen whether this mechanism has a role to play in GEA
3162-provoked apoptosis.
It is interesting to note that exogenous expression of
human Bcl-2 does not simply reduce caspase activity, but
abolishes it in both untreated and GEA 3162-exposed cells.
This is similar to the ‘complete’ inhibition of apoptosis
previously reported in various cell types on overexpression
b i o c h em i c a l p h a rma co l o g y 7 4 ( 2 0 0 7 ) 1 0 3 9 – 1 0 4 91048of Bcl-2 [33,38], and suggests that Bcl-2 may have a tighter
regulatory role on NO/ONOO-induced caspase activation
than mere mitochondrial stability. Additionally, all caspases
are equally affected by Bcl-2, rather than just those down-
stream of mitochondria (caspases 9 and 3) pointing to a more
general inhibitory effect than insertion of Bcl-2 into mito-
chondrial membranes. If only mitochondrial stability was
altered, it would be expected that caspases 2 and 8 would still
be elevated in the Jaws II-Bcl-2 cells. These data therefore
support the hypothesis that cytoprotection afforded by Bcl-2
occurs via a similar pathway to that observed in C. elegans by
CED-9.
The role of MAP kinases in cells is complex and somewhat
variable, with both pro- and anti-apoptotic effects being
reported, and is seemingly dependent upon the cell type being
investigated [7,8]. However, there is evidence to suggest that
both p38 and JNKMAP kinasesmay play a role inNO or ONOO
mediated cell death [39,40] as well as other apoptotic stimuli
[41] and Bcl-2 has been shown to suppress p38 activation and
subsequent NO-induced apoptosis [42], therefore it was
hypothesised that these kinases may be involved in GEA
3162-induced apoptosis of Jaws II cells. Studies using
pharmacological inhibitors of p38 and JNK demonstrated a
pro-apoptotic role for p38when Jaws II-GFP cells were exposed
to ONOO fromGEA 3162, but little or no role for JNK. However
the role of p38 is stimulus-specific, as this kinase has an anti-
apoptotic role when cells are exposed to STSP. Additional
studies examining the expression and phosphorylation status
of these MAP kinases would be useful in order to confirm and
further investigate the involvement of these proteins and their
role in ONOO-induced apoptosis.
Protein modification may occur in response to reactive
oxygen and nitrogen species, which may subsequently alter
protein function and cause cellular effects including apoptosis
[43]. One such modification, which may occur on exposure to
ONOO is formation of 3-nitrotyrosine (3-NT), in which
susceptible protein tyrosine residues may be nitrated [44].
Additional studies are required to assess formation of 3-NT,
and identification of target proteins, in Jaws II cells exposed to
GEA 3162, to determine whether this mechanism may have a
role in GEA 3162-induced apoptosis in these cells.
We have demonstrated an apoptotic response to ONOO in
a murine bonemarrow cell line. To the best of our knowledge,
this is the first time that apoptosis has been reportedusing this
cell line, and demonstrates that functional p53 is not a
requirement for ONOO mediated cell death in this cell type.
Furthermore, we have shown that caspases 2 and 3 are
important for apoptosis to proceed, with roles for caspases 8
and 9, and p38 MAP kinase. The anti-apoptotic protein, Bcl-2,
abolishes caspase activation involved in both intrinsic and
extrinsic pathways, suggesting a survival mechanism that is
not restricted solely to themitochondria, andmay represent a
novel or previously only speculativemechanism bywhich Bcl-
2 protects against apoptosis.
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